Vol. 24 (1-2) 2003 Neuro endocrinology letters

Perspectives of new potential therapeutic applications of somatostatin analogs.

: At the present time only two long-acting somatostatin (SS) analogs, octreotide and lanreotide, are commonly used in the routine therapy. Both analogs have a high affinity mainly to a somatostatin receptor subtype 2 (SSTR2). The established indications for SS analogs treatment include acromegaly, neuroendocrine tumors of the pancreas a.....